Alecensa (alectinib) is a tyrosine kinase inhibitor (TKI) that works specifically on a protein called anaplastic lymphoma kinase (ALK protein). Tyrosine kinases (TK) help to determine processes such as growth, differentiation, metabolism, and cell death, and are involved in signaling pathways – these are pathways that control and regulate the flow of information between cells and their outside environment. Research has linked abnormal TK activity or mutations to various cancers – one of these is non-small cell lung cancer. Anaplastic lymphoma kinase (ALK) mutations are present in approximately 5% of NSCLC cases, and by inhibiting this protein, Alecensa reduces the growth of ALK-positive metastatic NSCLC. Alecensa is only used in metastatic NSCLC that has been tested and confirmed to be ALK-positive.
What is the mechanism of action for Alecensa (alectinib)?
Featured questions
- How long do you take Alecensa for?
- How effective is Alecensa for ALK-positive NSCLC?
- What is Alecensa used to treat?
- How does Alecensa work?
- Can these drugs be used in Thalassemia patients?
- How does Lupron (leuprolide) work for prostate cancer?
- What is the consideration to use nifidepine over amlodipine?
- Hypertrophic cardiomyopathy/mechanical heart valve?
- I have been on 400mg of tramadol a day for 20 years, decided its time to come off them
- Cetirizine - can cetirizine be taken for long periods of time?
- In the 1960 and 1970 what was used to treat server asthma?
- High dosage of escitalopram?